Literature DB >> 19392586

Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.

Mohamed E Abdelrahim1, Henry Chrystyn.   

Abstract

Characterization of the aerosolized dose emitted from a nebulized system can be determined using CEN (prEN13544-1) methodology and more recently with a Next Generation Impactor (NGI), but evaporative effects can influence the results. We have investigated these characteristics using different flows and cooling with the NGI and compared the results to the standard CEN method using two different nebulizer systems. The NGI was operated using flows of 15 and 30 L min(-1) at room (ROOM) temperature and immediately after cooling at 5 degrees C for 90 min (COLD). Two nebulizer systems, the Sidestream jet nebulizer (SIDE) and the Aeroneb Pro (AERO), were used to nebulize terbutaline sulphate respiratory solution. The CEN method was also used to provide the aerodynamic characteristics of the aerosolized dose from these two nebulizer systems. The mean (SD) mass median aerodynamic diameter (MMAD) using 15COLD, 15ROOM, 30COLD, 30ROOM, and CEN for AERO was 5.0(0.1), 4.1(0.3), 4.4(0.2), 2.0(0.3), and 3.0(1.1) microm, respectively, and 4.2(0.4), 2.6(0.4), 3.5(0.1), 1.7(0.1), and 3.2(0.3) microm for SIDE. The fine particle fraction (FPF), using the NGI, followed the expected trend associated with the corresponding MMAD values, ranging from 48.1 to 70.5% from AERO and 57.3 to 87.8% for SIDE. The mean FPF for AERO and SIDE using the CEN methodology was 72.5 and 63.6%. Overall there was a highly significant difference (p < 0.001) between the different operating conditions for the FPF and MMAD of both nebulizer systems. All methods revealed a significant difference between AERO and SIDE except CEN. Both nebulizer systems were prone to evaporation effects during in vitro testing. Cooling and using a slow flow minimizes evaporation effects with the NGI and should be adopted as the recommended compendial method. The CEN method provides different values to those of the NGI operating conditions and could not differentiate between the two nebulizers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392586     DOI: 10.1089/jamp.2008.0650

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  9 in total

Review 1.  Aerosol delivery via noninvasive ventilation: role of models and bioanalysis.

Authors:  Haitham Saeed; Hadeer S Harb; Yasmin M Madney; Mohamed E A Abdelrahim
Journal:  Ann Transl Med       Date:  2021-04

2.  Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery.

Authors:  Minyi Guan; Xuan Zeng; Rui Shi; Yuying Zheng; Weiyang Fan; Weiwei Su
Journal:  AAPS PharmSciTech       Date:  2021-01-03       Impact factor: 3.246

3.  Production of Inhalable Submicrometer Aerosols from Conventional Mesh Nebulizers for Improved Respiratory Drug Delivery.

Authors:  P Worth Longest; Benjamin M Spence; Landon T Holbrook; Karla M Mossi; Yoen-Ju Son; Michael Hindle
Journal:  J Aerosol Sci       Date:  2012-04-14       Impact factor: 3.433

4.  Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers.

Authors:  Amir Amani; Peter York; Henry Chrystyn; Brian J Clark
Journal:  AAPS PharmSciTech       Date:  2010-07-24       Impact factor: 3.246

5.  Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.

Authors:  Snehal K Shukla; Apoorva Sarode; Dipti D Kanabar; Aaron Muth; Nitesh K Kunda; Samir Mitragotri; Vivek Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-15

6.  Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components.

Authors:  P Worth Longest; Laleh Golshahi; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

7.  Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.

Authors:  Ranjot Kaur; Sarah R Dennison; Andrea J Burrow; Shivaprakash M Rudramurthy; Rajan Swami; Varun Gorki; O P Katare; Anupama Kaushik; Bhupinder Singh; Kamalinder K Singh
Journal:  J Nanobiotechnology       Date:  2021-01-11       Impact factor: 10.435

8.  Aerosolizable Lipid-Nanovesicles Encapsulating Voriconazole Effectively Permeate Pulmonary Barriers and Target Lung Cells.

Authors:  Ranjot Kaur; Sarah R Dennison; Shivaprakash M Rudramurthy; O P Katare; Teenu Sharma; Bhupinder Singh; Kamalinder K Singh
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

9.  Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA.

Authors:  Thorben Fischer; Inga Winter; Robert Drumm; Marc Schneider
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.